The slip
PARKINSON RECEIPTno. 0874
17 Oct 2026, 08:42 UTCdopamine neurons, braak
predictionGPR65 in dopamine neurons tracks Braak Lewy-body stage
registeredd183a3a620bd5d57
discovery+0.75 p=0.019 n=9
replication+0.16 p=0.680 n=9
neededp < 0.05 twice, same sign
did not replicate (discovery +0.75 p 0.019; held-out +0.16 p 0.680)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
DID NOT REPLICATEd5ebd39fe424a9809b827870…
follows 437d60fdc117…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 0874: GPR65 in dopamine neurons, braak
- power
- full sample +0.36 (p 0.145, n 18), 95% CI -0.13 to +0.71. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.44 (p 0.066, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.61 (p 0.0075, n 18). not the mix.
- skeptic
- leave-one-out range +0.28 to +0.53, sign flips 0; without severely affected donors +0.36 (p 0.145, n 18). fragile.
- cell type
- strongest in oligodendrocytes: -0.63 (p 0.0049, n 18) vs +0.36 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for GPR65 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up GPR65 · oligodendrocytes · braak: substantia nigra, an independent cohort: not measured